Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of Two Protocols for Corporal Decolonization in Patients Colonized by Methicillin Resistant Staphylococcus Aureus (MRSA)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~- MRSA infected or colonized Patients~Exclusion Criteria:~Patients whose condition or treatment interferes with the proper implementation of the proposed protocols, such as:~* Patients admitted to the ICU~* Patients undergoing resuscitation~* Immobilized patients-avoiding their complete hygiene~* Patients carrying nasogastric tube~* Patients with tracheostomy and / or assisted mechanical ventilation~* Patients who are unable, neither they nor their representatives, to give valid informed consent.~* Patients whose discharged is planned before completing protocol

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Chlorhexidine + Mupirocin (Type: ACTIVE_COMPARATOR): Will be treated with the protocol described in the Consensus document and GEIH-SEIMC SEMPSPH Version 31/10/07, as shown listed in Table 4. It is a protocol of 5 days (nasal mupirocin and chlorhexidine, potentially plus systemic antibiotics and 7 days).
- Prontoderm (Type: EXPERIMENTAL): Will be treated with the protocol established for Prontoderm® for five days and eventually plus systemic antibiotics.

Based on this trial design, predict the completion outcome and termination type (if applicable).